Trial NCT03080935

View at ClinicalTrials.gov 
Org. Study IDs: 20160250
Secondary IDs: 2016-004066-26

Last trial update was posted on 2023-03-08

MeSH Interventions

Evolocumab

MeSH Conditions

Cardiovascular Diseases Dyslipidemias

Other Conditions

Dyslipidemia

Stopping Reasons

Amgen business decision to close study early

Limitations And Caveats

This study was terminated to coincide with the completion of study 20130295 (NCT02867813). The study was not terminated due to any safety findings.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID